MTOR and central nervous system cancer: Building on these findings mTOR inhibitors may offer a novel therapeutic avenue in glioma—not solely for tumor suppression, but for mitigating the tumor-induced neurological dysfunction seen consistently in both preclinical models and in clinical care [11,145].